Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.37 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.37 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.37 |
| ▸ | PPARA | Q07869 | 3/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | CA6 | P23280 | 1/20 | 0.35 |
| ▸ | CA5A | P35218 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.35 |
| ▸ | MET | P08581 | 1/20 | 0.35 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.34 |
| ▸ | ACR | P10323 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2138504 | 0.93 | MAPT (0.39) | MAPTKDM4EABCG2CYP1A1CYP1B1 | |
| SCHEMBL28648623 | 0.93 | MAPT (0.39) | MAPTKDM4EABCG2CYP1A1CYP1B1 | |
| SCHEMBL30086264 | 0.93 | ABCG2 (0.40) | MAPTKDM4EABCG2CYP1A1CYP1B1 | |
| SCHEMBL18112629 | 0.93 | ABCG2 (0.40) | MAPTKDM4EABCG2CYP1A1CYP1B1 | |
| SCHEMBL679372 | 0.93 | ABCG2 (0.40) | MAPTKDM4EABCG2CYP1A1CYP1B1 | |
| SCHEMBL2138428 | 0.92 | MAPT (0.38) | MAPTKDM4EABCG2CYP1A1CYP1B1 | |
| SCHEMBL28657773 | 0.92 | MAPT (0.38) | MAPTKDM4EABCG2CYP1A1CYP1B1 | |
| SCHEMBL2140710 | 0.88 | MAPT (0.38) | MAPTKDM4EABCG2CYP1A1CYP1B1 | |
| SCHEMBL28664683 | 0.88 | MAPT (0.38) | MAPTKDM4EABCG2CYP1A1CYP1B1 | |
| SCHEMBL678505 | 0.88 | MAPT (0.40) | MAPTKDM4EABCG2CYP1A1CYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9976088-B2 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element having the same | CHI MEI CORPORATION (TW) | 2018-05-22 | — | — | US | disclosed |
| US-9976088-B2 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element having the same | CHI MEI CORPORATION (TW) | 2018-05-22 | — | — | US | disclosed |
| US-20170362381-A1 | THERMALLY STABLE ALIGNMENT MATERIALS | ROLIC AG (CH) | 2017-12-21 | — | — | US | disclosed |
| US-20170362381-A1 | THERMALLY STABLE ALIGNMENT MATERIALS | ROLIC AG (CH) | 2017-12-21 | — | — | US | disclosed |
| US-9644147-B2 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | CHI MEI CORPORATION (TW) | 2017-05-09 | — | — | US | disclosed |
| US-9644147-B2 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | CHI MEI CORPORATION (TW) | 2017-05-09 | — | — | US | disclosed |
| US-20170029703-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT HAVING THE SAME | CHI MEI CORPORATION (TW) | 2017-02-02 | — | — | US | disclosed |
| US-20170029703-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT HAVING THE SAME | CHI MEI CORPORATION (TW) | 2017-02-02 | — | — | US | disclosed |
| US-9505981-B2 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device | CHI MEI CORPORATION (TW) | 2016-11-29 | — | — | US | disclosed |
| US-9505981-B2 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device | CHI MEI CORPORATION (TW) | 2016-11-29 | — | — | US | disclosed |
| US-20120076952-A1 | PHOTOCROSSLINKABLE MATERIALS | ROLIC AG (CH) | 2012-03-29 | — | — | US | disclosed |
| EP-2308827-A1 | Photocrosslinkable materials | Rolic AG (CH) | 2011-04-13 | — | — | EP | disclosed |
| EP-2308826-A1 | Photocrosslinkable materials | Rolic AG (CH) | 2011-04-13 | — | — | EP | disclosed |
| EP-2305632-A1 | Photocrosslinkable materials | Rolic AG (CH) | 2011-04-06 | — | — | EP | disclosed |
| EP-2305631-A1 | Photocrosslinkable materials | Rolic AG (CH) | 2011-04-06 | — | — | EP | disclosed |
| US-20110065859-A1 | THERMALLY STABLE ALIGNMENT MATERIALS | ROLIC AG (CH) | 2011-03-17 | — | — | US | disclosed |
| US-20110065859-A1 | THERMALLY STABLE ALIGNMENT MATERIALS | ROLIC AG (CH) | 2011-03-17 | — | — | US | disclosed |
| US-20080293888-A1 | Photocrosslinkable Materials | ROLIC AG (CH) | 2008-11-27 | — | — | US | disclosed |
| US-20080293888-A1 | Photocrosslinkable Materials | ROLIC AG (CH) | 2008-11-27 | — | — | US | disclosed |
| EP-1860094-A1 | Photocrosslinkable materials | Rolic AG (CH) | 2007-11-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080293888-A1 | Photocrosslinkable Materials | DDC, PARG, ALAD | MAPT 295/4885KDM4E 1831/4885ABCG2 4577/4885 |
| US-20120076952-A1 | PHOTOCROSSLINKABLE MATERIALS | DDC, PARG, ALAD | MAPT 295/4885KDM4E 1831/4885ABCG2 4577/4885 |
| US-20110065859-A1 | THERMALLY STABLE ALIGNMENT MATERIALS | PARG, PARN, PUF60 | MAPT 159/4885KDM4E 2018/4885ABCG2 3643/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.